Institut Du Cancer De Montpellier - Val D'aurelle
Clinical trials sponsored by Institut Du Cancer De Montpellier - Val D'aurelle, explained in plain language.
-
MRI-Guided therapy could spare rectal cancer patients unnecessary surgery
Disease control Recruiting nowThis study aims to personalize treatment for people with locally advanced rectal cancer. After a short course of chemotherapy, an MRI will identify those who respond very well. These good responders will then be randomly assigned to either immediate surgery or additional chemorad…
Phase: PHASE2, PHASE3 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Tailored radiation aims to cut breast cancer treatment toxicity
Disease control Recruiting nowThis study tests a personalized approach to breast radiotherapy, selecting the right dose and technique based on each patient's risk of cancer returning and their chance of side effects. It involves 854 women with invasive breast cancer who have had surgery. The main goal is to s…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Yoga and PT offer hope for breast cancer patients suffering from hormone therapy pain
Symptom relief Recruiting nowThis study tests whether a program combining physical therapy, yoga, and patient education can reduce joint and muscle pain caused by hormone therapy in breast cancer patients. About 108 adults with non-metastatic breast cancer and moderate-to-severe pain will be randomly assigne…
Phase: NA • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC